Denali Therapeutics shares owned by Carillon Tower Advisers
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Carillon Tower Advisers
from 13F filings
Historical chart of Carillon Tower Advisers investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Carillon Tower Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Carillon Tower Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2020-12-31 | $18M | 210k | 83.76 |